Cite

1. Brammås A, Jakobsson S, Ulvenstam A, Mooe T. Mortality after ischemic stroke in patients with acute myocardial infarction: predictors and trends over time in Sweden. Stroke. 2013;44(11):3050-5.10.1161/STROKEAHA.113.001434Search in Google Scholar

2. Ulvenstam A, Kajermo U, Modica A, Jernberg T, Söderström L, Mooe T. Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction. Stroke. 2014;45(11):3263-8.10.1161/STROKEAHA.114.005770Search in Google Scholar

3. Kajermo U, Ulvenstam A, Modica A, Jernberg T, Mooe T. Incidence, trends, and predictors of ischemic stroke 30 days after an acute myocardial infarction. Stroke. 2014;45(5):1324-30.10.1161/STROKEAHA.113.001963Search in Google Scholar

4. Jakobsson S, Graipe A, Huber D, Björklund F, Mooe T. The risk of ischemic stroke after an acute myocardial infarction in patients with decreased renal function. Cerebrovasc Dis. 2014;37(6):460-9.10.1159/000363616Search in Google Scholar

5. Kovacik M, Madarasz S, Kral M, Veverka T, Herzig R, Kanovsky P. Risk factors associated with ischemic heart disease occurence in acute ischemic stroke patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(2):168-71.10.5507/bp.2011.069Search in Google Scholar

6. Naderi N, Masoomi H, Mozaffar T, Malik S. Patient characteristics and comorbidities associated with cerebrovascular accident following acute myocardial infarction in the United States. Int J Cardiol. 2014;175(2):323-7.10.1016/j.ijcard.2014.05.024Search in Google Scholar

7. Gattringer T, Niederkorn K, Seyfang L, Seifert-Held T, Simmet N, Ferrari J, et al. Myocardial infarction as a complication in acute stroke: results from the Austrian stroke unit registry. Cerebrovasc Dis. 2014;37(2):147-52.10.1159/000357799Search in Google Scholar

8. Jakobsson S, Bergström L, Björklund F, Jernberg T, Söderström L, Mooe T. Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus. Circ Cardiovasc Qual Outcomes. 2014;7(1):95-101.10.1161/CIRCOUTCOMES.113.000311Search in Google Scholar

9. Gu L, Liu W, Yan Y, Su L, Wu G, Liang B, et al. Influence of the β-fibrinogen-455G/A polymorphism on development of ischemic stroke and coronary heart disease. Thromb Res. 2014;133(6):993-1005.10.1016/j.thromres.2014.01.001Search in Google Scholar

10. Iso H, Noda H, Ikeda A, Yamagishi K, Inoue M, Iwasaki M, et al. The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study. J Atheroscler Thromb. 2012;19(8):756-66.10.5551/jat.11999Search in Google Scholar

11. Iwasaki K, Haraoka K, Hamaguchi T, Imamura T, Kawada S, Ohno M, et al. Prevalence of subclinical coronary artery disease in ischemic stroke patients. J Cardiol. 2015;65(1):71-5.10.1016/j.jjcc.2014.04.004Search in Google Scholar

12. Wu DF, Yin RX, Cao XL, Chen WX. Association between single nucleotide polymorphism rs1044925 and the risk of coronary artery disease and ischemic stroke. Int J Mol Sci. 2014;15(3):3546-59.10.3390/ijms15033546Search in Google Scholar

13. Hoshino T, Ishizuka K, Shimizu S, Uchiyama S. CHADS2, CHA2DS2-VASc, and R2CHADS2 scores are associated with 3-month functional outcome of stroke in patients with prior coronary artery disease. Circ J. 2014;78(6):1481-5.10.1253/circj.CJ-14-0038Search in Google Scholar

14. González-Pacheco H, Méndez-Domínguez A, Vieyra-Herrera G, Azar-Manzur F, Meave-González A, Rodríguez-Zanella H, et al. Reperfusion strategy for simultaneous ST-segment elevation myocardial infarction and acute ischemic stroke within a time window. Am J Emerg Med. 2014;32(9):1157.e1-4.10.1016/j.ajem.2014.02.047Search in Google Scholar

15. Dregan A, Charlton J, Wolfe CD, Gulliford MC, Markus HS. Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study. Pharmacoepidemiol Drug Saf. 2014;23(7):759-67.10.1002/pds.3651Search in Google Scholar

16. Thomas K, Kessler C. New antiplatelet agents prescribed to patients with ischemic heart disease: implications for treatment of stroke. Curr Treat Options Neurol. 2014;16(5):289.10.1007/s11940-014-0289-2Search in Google Scholar

eISSN:
1313-9053
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Ophthalmology, Public Health, Pharmacy, Clinical Pharmacy